Yeast cells can be used for rapid testing of cancer immunotherapy
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-May-2026 23:15 ET (1-Jun-2026 03:15 GMT/UTC)
The use of medicines to address mental health or behavioral conditions climbed from 2001 until 2020, analysis showed, but the increase has led to safety concerns
Breast cancer (BC) is the most common cancer and the second leading cause of cancer death in women. It is a highly variable disease, defined as a malignancy of the epithelial ducts in breast tissue. Characterizing the vast heterogeneity within BC cells and their surrounding tumor microenvironment is crucial because this diversity is the primary reason for treatment resistance, disease progression and poor patient prognosis.
In a new study from Boston University Chobanian & Avedisian School of Medicine, researchers assembled a comprehensive single-cell atlas of the human breast, combining data from 138 patients and more than 600,000 single cells. They then were able to identify cell populations and cell states that previously were unclear or missed and linked these cell types to tumor features (like subtype and grade) and patient outcomes.